FRANCE – ABL Biotechnologies, a South Korean biotechnology firm, has signed a global licensing and exclusive collaboration agreement with Sanofi to develop and commercialize a new Parkinson’s disease therapy candidate.…
Read MoreSanofi in groundbreaking deal with ABL Bio to develop Parkinson’s disease drug
